TrialPanorama/TrialPanorama-database huggingface dataset:
Study 8645368 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 9451346 — Surrogate Endpoint (SUR): Serum sodium
Study 3996194 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 31892533 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 31892533 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22354408 — Surrogate Endpoint (SUR): Bone mineral density
Study 20420907 — Surrogate Endpoint (SUR): Blood pressure
Study 12401856 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 12401856 — Surrogate Endpoint (SUR): Serum creatinine
Study 25469528 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 25469528 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 25469528 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 25469528 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25469528 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 25469528 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21091547 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 19743983 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 19743983 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 16514568 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study 27142632 — Surrogate Endpoint (SUR): Bone mineral density
Study 20507310 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 22011650 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 22019482 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 20164315 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 2573113 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 28246888 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 17919835 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study 27908668 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 27908668 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 26563497 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26563497 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 26563497 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 14685103 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 12236325 — Surrogate Endpoint (SUR): Blood pressure
Study 31919090 — Predictive Biomarker (PRD): NOTCH1 mRNA
Genes: NOTCH1; TAN1
Study 31919090 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 31919090 — Predictive Biomarker (PRD): RPS15 mRNA
Genes: RPS15; RIG
Study 31919090 — Predictive Biomarker (PRD): MYD88 mRNA
Genes: MYD88
Study 31919090 — Predictive Biomarker (PRD): BIRC3 mRNA
Genes: BIRC3; API2; MIHC; RNF49
Study 28728565 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 28728565 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 24942481 — Predictive Biomarker (PRD): PICALM mRNA
Genes: PICALM; CALM
Study 12398959 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 12398959 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 12398959 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31202641 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31202641 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 31202641 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25567775 — Surrogate Endpoint (SUR): Bone mineral density
Study 17224000 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 17224000 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study 17224000 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 17224000 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 27274772 — Surrogate Endpoint (SUR): Blood pressure
Study 27274772 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15868120 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15868120 — Surrogate Endpoint (SUR): Blood pressure
Study 2692983 — Predictive Biomarker (PRD): FLNB mRNA
Genes: FLNB; FLN1L; FLN3; TABP; TAP
Study 23494328 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19453049 — Surrogate Endpoint (SUR): Blood pressure
Study 16442399 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25194409 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25194409 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study 14551895 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19115911 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 3609120 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 3609120 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 23932463 — Surrogate Endpoint (SUR): Blood pressure
Study 20974292 — Surrogate Endpoint (SUR): Blood pressure
Study 11342474 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 9412794 — Surrogate Endpoint (SUR): Serum testosterone
Study 8433078 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 2688186 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 29427081 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 27711100 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 23033982 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23033982 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 8731496 — Surrogate Endpoint (SUR): Blood pressure
Study 31699150 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31699150 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 27362585 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study 25293478 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 7951338 — Surrogate Endpoint (SUR): Serum testosterone
Study 28182335 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study 26050057 — Surrogate Endpoint (SUR): Blood pressure
Study 19381735 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 9150480 — Surrogate Endpoint (SUR): Blood pressure
Study 9116382 — Surrogate Endpoint (SUR): Blood pressure
Study 19118791 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 15054445 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 15054445 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 1756022 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15816462 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 15816462 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 15816462 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29633268 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study 27999758 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study 10658277 — Surrogate Endpoint (SUR): Blood pressure
Study 25100270 — Surrogate Endpoint (SUR): Blood pressure
Study 22570949 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22570949 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 22570949 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 16197471 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MUC5AC mRNA
Genes: MUC5AC; MUC5
Study 16197471 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 27929185 — Predictive Biomarker (PRD): RAB8A mRNA
Genes: RAB8A; MEL; RAB8
Study 25355780 — Surrogate Endpoint (SUR): Blood pressure
Study 8433075 — Surrogate Endpoint (SUR): Blood pressure
Study 27281302 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 27281302 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study 27281302 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20888307 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study 20888307 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 14650643 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study 8653019 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8653019 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 1455403 — Predictive Biomarker (PRD): DHPS mRNA
Genes: DHPS; DS
Study 1455403 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 26886262 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 20630595 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 20630595 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 17599560 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study 17599560 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 17599560 — Predictive Biomarker (PRD): CX3CL1 mRNA
Genes: CX3CL1; FKN; NTT; SCYD1; A-152E5.2
Study 17599560 — Predictive Biomarker (PRD): LTB4R mRNA
Genes: LTB4R; BLT; BLT1; BLTR; CMKRL1; GPR16; P2RY7
Study 8297690 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 25531162 — Predictive Biomarker (PRD): MAP3K5 mRNA
Genes: MAP3K5; ASK1; MAPKKK5; MEKK5
Study 24101040 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 12064924 — Surrogate Endpoint (SUR): Bone mineral density
Study 7531326 — Safety Biomarker (SAF): BCHE
Genes: E1
Study 7531326 — Surrogate Endpoint (SUR): Blood pressure
Study 28924366 — Surrogate Endpoint (SUR): Blood pressure
Study 25264671 — Predictive Biomarker (PRD): MAX mRNA
Genes: MAX; BHLHD4
Study 17301074 — Predictive Biomarker (PRD): Hormone receptor
Study 31721978 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 27037007 — Predictive Biomarker (PRD): POR mRNA
Genes: POR; CYPOR
Study 29373734 — Surrogate Endpoint (SUR): Serum testosterone
Study 27832623 — Predictive Biomarker (PRD): SP9 mRNA
Genes: SP9
Study 29880291 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 21700754 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 21700754 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 21700754 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21700754 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 18086726 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 27805982 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 9331007 — Surrogate Endpoint (SUR): Blood pressure
Study 17550442 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 2180536 — Surrogate Endpoint (SUR): Forced vital capacity
Study 94528 — Surrogate Endpoint (SUR): Bacterial count
Study 12040348 — Surrogate Endpoint (SUR): Blood pressure
Study 9734653 — Predictive Biomarker (PRD): PGP mRNA
Genes: PGP
Study 2648779 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 31955207 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 15975107 — Surrogate Endpoint (SUR): Blood pressure
Study 30742868 — Predictive Biomarker (PRD): LCAT mRNA
Genes: LCAT
Study 16313289 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 1463596 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 31842106 — Predictive Biomarker (PRD): LSS mRNA
Genes: LSS; OSC
Study 31136089 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study 25861793 — Surrogate Endpoint (SUR): Blood pressure
Study 19063649 — Surrogate Endpoint (SUR): Blood pressure
Study 17928991 — Surrogate Endpoint (SUR): Serum uric acid
Study 7959618 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 22585012 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 28976540 — Pharmacodynamic Biomarker (PDY): Error related negativity
Study 15661480 — Surrogate Endpoint (SUR): Blood pressure
Study 15661480 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15661480 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 31237119 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 23650172 — Monitoring Biomarker (MOI): HBV DNA
Study 9627768 — Surrogate Endpoint (SUR): Blood pressure
Study 3257843 — Surrogate Endpoint (SUR): Bone mineral density
Study 19248046 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 17443208 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 17443208 — Surrogate Endpoint (SUR): Blood pressure
Study 12874615 — Surrogate Endpoint (SUR): Blood pressure
Study 23973555 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 9310003 — Predictive Biomarker (PRD): SMG1 mRNA
Genes: SMG1; ATX; KIAA0421; LIP
Study 30933616 — Predictive Biomarker (PRD): COG2 mRNA
Genes: COG2; LDLC
Study 3111705 — Surrogate Endpoint (SUR): Serum calcium
Study 29254887 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 29254887 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 29254887 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study 29254887 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 29254887 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 29254887 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 7567007 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 2362952 — Pharmacodynamic Biomarker (PDY): Homovanillic acid
Study 16872504 — Surrogate Endpoint (SUR): Blood pressure
Study 10853210 — Surrogate Endpoint (SUR): Blood pressure
Study 8499682 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 27302744 — Surrogate Endpoint (SUR): Blood pressure
Study 15657157 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 15657157 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 22034636 — Surrogate Endpoint (SUR): Serum creatinine
Study 20451454 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 18504369 — Monitoring Biomarker (MOI): Procalcitonin
Study 18504369 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 18504369 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25307535 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25307535 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 23041150 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 23041150 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 18022000 — Surrogate Endpoint (SUR): Serum creatinine
Study 7677832 — Surrogate Endpoint (SUR): Blood pressure
Study 8632624 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 24424141 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 21979997 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 23944648 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 11157143 — Safety Biomarker (SAF): Interleukin 1
Study 9593066 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 9593066 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 9593066 — Surrogate Endpoint (SUR): Serum testosterone
Study 7528305 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 7528305 — Surrogate Endpoint (SUR): Blood pressure
Study 26259598 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 26259598 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 15126521 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 7520248 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29151359 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 22520521 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 16214012 — Surrogate Endpoint (SUR): Bone mineral density
Study 28746195 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 28746195 — Safety Biomarker (SAF): IL-6 and IL-10
Study 23542639 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19343272 — Surrogate Endpoint (SUR): Bone mineral density
Study 1352497 — Surrogate Endpoint (SUR): Blood pressure
Study 19347843 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 14716221 — Surrogate Endpoint (SUR): Blood pressure
Study 2607520 — Surrogate Endpoint (SUR): Blood pressure
Study 24079100 — Surrogate Endpoint (SUR): Probing pocket depth
Study 30575059 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 27442130 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 25124078 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 3667020 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 24005613 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 24005613 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 8387346 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 8387346 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 25713647 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 25713647 — Surrogate Endpoint (SUR): Blood pressure
Study 20813681 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 20813681 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 20813681 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study 9600795 — Surrogate Endpoint (SUR): Bone mineral density
Study 30690446 — Surrogate Endpoint (SUR): Bone mineral density
Study 29505549 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 10036846 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 2046107 — Surrogate Endpoint (SUR): Blood pressure
Study 27129124 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 19718777 — Predictive Biomarker (PRD): Leucine-rich alpha-2-glycoprotein
Genes: LRG1; LRG
Study 9719743 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 9719743 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24075770 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 24075770 — Predictive Biomarker (PRD): Hormone receptor
Study 24075770 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29099333 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 25599107 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 15505069 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 8398831 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 8398831 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 8398831 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 17179022 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 11514956 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 11514956 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 11514956 — Predictive Biomarker (PRD): Proliferation marker protein Ki-67
Genes: MKI67
Study 7915348 — Surrogate Endpoint (SUR): Blood pressure
Study 27038550 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study 19400874 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 27016000 — Predictive Biomarker (PRD): GDNF mRNA
Genes: GDNF